BriaCell Therapeutics Corp. Common Shares (NASDAQ: BCTX)
$0.93
+0.0042 ( +0.45% ) 144.7K
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Market Data
Open
$0.93
Previous close
$0.93
Volume
144.7K
Market cap
$16.72M
Day range
$0.88 - $0.96
52 week range
$0.85 - $7.59
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 14 | Jul 05, 2024 |
| 8-k | 8K-related | 24 | Jun 14, 2024 |
| 10-q | Quarterly Reports | 62 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | May 20, 2024 |
| 8-k | 8K-related | 26 | May 17, 2024 |
| 8-k | 8K-related | 24 | Apr 02, 2024 |
| 10-q | Quarterly Reports | 59 | Mar 18, 2024 |
| 8-k | 8K-related | 15 | Jan 31, 2024 |
| def | Proxies and info statements | 9 | Jan 09, 2024 |
| 8-k | 8K-related | 15 | Dec 20, 2023 |